Myeloproliferative syndrome with sideroblastic anemia and acquired hemoglobin H disease.
Hemoglobin H disease usually occurs as a result of inheritance of the genes for alpha thalassemia; however, occasionally patients acquire hemoglobin H in association with hematologic malignancy. This report concerns a 63-year-old Filipino man with a myeloproliferative syndrome with marked thrombocytosis and apparently acquired hemoglobulin H disease. The patient had hemolytic anemia, dimorphic red blood cells (RBC) and abundant ringed sideroblasts in the marrow. The peripheral blood contained 27% hemoglobin H and about two-thirds of his RBC had hemoglobin H inclusion bodies. There was no previous history of anemia or evidence of thalassemia in two siblings or nine adult children of the patient. In vitro studies of globin chain synthesis documented markedly decreased production of alpha globin with alpha/beta biosynthetic ratios of 0.05 in peripheral blood reticulocytes and 0.10 in bone marrow cells. The relative concentration of mRNA for alpha globin was approximately 20-fold less than that of beta globin, apparently accounting for the deficiency in alpha globin synthesis.
D000756:Anemia, Sideroblastic / Q000150:complications* / Q000378:metabolism; D005914:Globins / Q000096:biosynthesis; D006447:Hemoglobin H; D006455:Hemoglobins, Abnormal; D006801:Humans; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D013577:Syndrome; D013789:Thalassemia / Q000150:complications* / Q000378:metabolism
D006455:Hemoglobins, Abnormal; D012333:RNA, Messenger; D005914:Globins; D006447:Hemoglobin H